Verve Therapeutics Company
![](/files/companies/Verve%20Therapeutics.jpg)
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2018
Employee Number:
1-10
Technology:
Small Molecules
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
PharmTech